BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16434296)

  • 1. Long-term survival after excision of a solitary esophageal cancer brain metastasis.
    Kesler KA; Hammoud ZT; Helft PR; Rieger KM; Pritz MB; Brown JW
    J Thorac Cardiovasc Surg; 2006 Feb; 131(2):497-8. PubMed ID: 16434296
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain metastasis in patients with esophageal carcinoma.
    Yoshida S
    Surg Neurol; 2007 Mar; 67(3):288-90. PubMed ID: 17320640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Brain metastasis as the presenting form of esophageal adenocarcinoma].
    Guilarte López-Mañas J; Bellot García V; Guerrero Fernández M; De Luna S
    Rev Esp Enferm Dig; 1997 Nov; 89(11):868-9. PubMed ID: 9580206
    [No Abstract]   [Full Text] [Related]  

  • 4. Brain metastasis from esophageal carcinoma.
    Agrawal R; Shukla P; Shukla V; Chauhan A
    J Cancer Res Ther; 2009; 5(2):137-9. PubMed ID: 19542674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival after resection of a lung cancer metastasis.
    Fotakopoulos G; Alexiou GA; Goussia A; Voulgaris S
    J Cancer Res Ther; 2011; 7(2):230-1. PubMed ID: 21768726
    [No Abstract]   [Full Text] [Related]  

  • 6. Brain metastases from esophageal cancer: a phenomenon of adjuvant therapy?
    Rice TW; Khuntia D; Rybicki LA; Adelstein DJ; Vogelbaum MA; Mason DP; Murthy SC; Blackstone EH
    Ann Thorac Surg; 2006 Dec; 82(6):2042-9, 2049.e1-2. PubMed ID: 17126108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracranial treatment for solitary prostatic adenocarcinoma brain metastasis is curative.
    Sweets T; Bracken RB; Geisler EJ; Warnick R
    Urology; 2009 Mar; 73(3):681.e7-9. PubMed ID: 18502485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.
    Greenstein AJ; Litle VR; Swanson SJ; Divino CM; Packer S; Wisnivesky JP
    Cancer; 2008 Mar; 112(6):1239-46. PubMed ID: 18224663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection.
    Peyre CG; Hagen JA; DeMeester SR; Altorki NK; Ancona E; Griffin SM; Hölscher A; Lerut T; Law S; Rice TW; Ruol A; van Lanschot JJ; Wong J; DeMeester TR
    Ann Surg; 2008 Oct; 248(4):549-56. PubMed ID: 18936567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cases of brain metastasis presenting as the first sign of systemic cancer.
    Chee CP; Byrnes DP
    Singapore Med J; 1988 Jun; 29(3):252-6. PubMed ID: 3187577
    [No Abstract]   [Full Text] [Related]  

  • 12. Solitary cerebral metastasis. Long-term survival following surgery.
    Goran A; Murthy KK
    N Y State J Med; 1977 Sep; 77(11):1780-2. PubMed ID: 408766
    [No Abstract]   [Full Text] [Related]  

  • 13. Testicular metastasis from adenocarcinoma of the esophagus.
    Gillen S; Feith M; Gertler R; Langer R; Massmann J; Sarbia M; Friess H
    Ann Thorac Surg; 2009 Mar; 87(3):957-9. PubMed ID: 19231438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total number of resected lymph nodes predicts survival in esophageal cancer.
    Altorki NK; Zhou XK; Stiles B; Port JL; Paul S; Lee PC; Mazumdar M
    Ann Surg; 2008 Aug; 248(2):221-6. PubMed ID: 18650631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
    Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
    Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node classification of esophageal squamous cell carcinoma and adenocarcinoma.
    Tachibana M; Kinugasa S; Hirahara N; Yoshimura H
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):427-31. PubMed ID: 18502142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of hospital volume on long-term survival after esophageal cancer surgery.
    Rouvelas I; Lindblad M; Zeng W; Viklund P; Ye W; Lagergren J
    Arch Surg; 2007 Feb; 142(2):113-7; discussion 118. PubMed ID: 17309961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
    Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
    Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma.
    Gockel I; Schimanski CC; Heinrich C; Wehler T; Frerichs K; Drescher D; von Langsdorff C; Domeyer M; Biesterfeld S; Galle PR; Junginger T; Moehler M
    BMC Cancer; 2006 Dec; 6():290. PubMed ID: 17176471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.